These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31733338)

  • 61. A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men.
    Barden AE; Chavez V; Phillips M; Mas E; Beilin LJ; Croft KD; Mori TA; Puddey IB
    Alcohol Clin Exp Res; 2017 Oct; 41(10):1666-1674. PubMed ID: 28767146
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dietary Polyphenols Inhibit the Cytochrome P450 Monooxygenase Branch of the Arachidonic Acid Cascade with Remarkable Structure-Dependent Selectivity and Potency.
    Kampschulte N; Alasmer A; Empl MT; Krohn M; Steinberg P; Schebb NH
    J Agric Food Chem; 2020 Aug; 68(34):9235-9244. PubMed ID: 32786866
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cytochrome P450-CYP2 Family-Epoxygenase Role in Inflammation and Cancer.
    Chen C; Wang DW
    Adv Pharmacol; 2015; 74():193-221. PubMed ID: 26233908
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids.
    Konkel A; Schunck WH
    Biochim Biophys Acta; 2011 Jan; 1814(1):210-22. PubMed ID: 20869469
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytochrome P450: major player in reperfusion injury.
    Gottlieb RA
    Arch Biochem Biophys; 2003 Dec; 420(2):262-7. PubMed ID: 14654065
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Eicosanoid formation by a cytochrome P450 isoform expressed in the pharynx of Caenorhabditis elegans.
    Kosel M; Wild W; Bell A; Rothe M; Lindschau C; Steinberg CE; Schunck WH; Menzel R
    Biochem J; 2011 May; 435(3):689-700. PubMed ID: 21309752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytochrome P450-derived eicosanoids in brain: From basic discovery to clinical translation.
    Davis CM; Ibrahim AH; Alkayed NJ
    Adv Pharmacol; 2023; 97():283-326. PubMed ID: 37236762
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states.
    Shoieb SM; El-Sherbeni AA; El-Kadi AOS
    Chem Biol Interact; 2019 Feb; 299():140-150. PubMed ID: 30543782
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
    Spiecker M; Liao JK
    Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Longitudinal profiles of plasma eicosanoids during pregnancy and size for gestational age at delivery: A nested case-control study.
    Welch BM; Keil AP; van 't Erve TJ; Deterding LJ; Williams JG; Lih FB; Cantonwine DE; McElrath TF; Ferguson KK
    PLoS Med; 2020 Aug; 17(8):e1003271. PubMed ID: 32797061
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways.
    Divanovic S; Dalli J; Jorge-Nebert LF; Flick LM; Gálvez-Peralta M; Boespflug ND; Stankiewicz TE; Fitzgerald JM; Somarathna M; Karp CL; Serhan CN; Nebert DW
    J Immunol; 2013 Sep; 191(6):3347-57. PubMed ID: 23956430
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis.
    Frömel T; Fleming I
    Antioxid Redox Signal; 2015 May; 22(14):1273-92. PubMed ID: 25330284
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytochrome P450 and liver diseases.
    Villeneuve JP; Pichette V
    Curr Drug Metab; 2004 Jun; 5(3):273-82. PubMed ID: 15180496
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale.
    Calder PC
    Biochimie; 2009 Jun; 91(6):791-5. PubMed ID: 19455748
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases.
    Giudetti AM; Cagnazzo R
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):57-67. PubMed ID: 23064030
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Eicosanoid pathway in colorectal cancer: Recent updates.
    Tuncer S; Banerjee S
    World J Gastroenterol; 2015 Nov; 21(41):11748-66. PubMed ID: 26557000
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma.
    Xu YJ; Zheng Z; Cao C; Li J; Liu Y
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):269-277. PubMed ID: 29934821
    [TBL] [Abstract][Full Text] [Related]  

  • 78. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polyunsaturated fatty acids and inflammation.
    Calder PC
    Prostaglandins Leukot Essent Fatty Acids; 2006 Sep; 75(3):197-202. PubMed ID: 16828270
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases.
    Capdevila JH; Falck JR
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():325-44. PubMed ID: 12432927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.